American Medical Association, CMS, Group purchasing organization, Health, Medicaid, Medicine, Patient Protection and Affordable Care Act, Physician, Press release, Research, science, State Children's Health Insurance Program
CMS issues final rule on Physician Payment Sunshine Act
February 4, 2013
CMS recently announced in a press release its final rule on the National Physician Payment Transparency Program: Open Payments, also known as the Sunshine Act, aimed to increase transparency among physicians, drug and device manufacturers and health care providers.
As part of the Affordable Care Act, the rule calls for manufacturers of drugs, devices, biologics and medical supplies reimbursed by Medicare, Medicaid or Children’s Health Insurance Program to disclose payments made to doctors and teaching hospitals to CMS. According to the release, these manufacturers and group purchasing organizations must also report physician ownership and investments in these enterprises. This data will be publicly available on a CMS website by September 30, 2014, and entities required to report information under the rule will be able to review and correct reported data before it is released to the public. Collection of this information will begin August 1 of this year, according to the release.
“You should know when your doctor has a financial relationship with the companies that manufacture or supply the medicines or medical devices you may need,” Peter Budetti, MD, CMS deputy administrator for Program Integrity, stated in the press release. “Disclosure of these relationships allows patients to have more informed discussions with their doctors.”
AMA President Jeremy Lazarus, MD, stated that the AMA will carefully review the new rule.
“Physicians’ relationships with the pharmaceutical industry should be transparent and focused on benefits to patients,” Lazarus stated in an AMA press release. “Our feedback during this rulemaking process was aimed at ensuring the new registry will provide a meaningful picture of physician-industry interactions and give physicians an easy way to correct any inaccuracies. As the rule is implemented, we will work to make sure physicians have up-to-date information about the new reporting process.”
Click to view a chart from Arnold & Porter LLC that provides more detailed information on key aspects of the rule, including comparisons between the proposed and final rules and brief summaries of CMS’ stated rationale for its decisions.
- The Sunshine Act Will Cost Pharma and Medical Device Manufacturers Hundreds of Millions of Dollars (diseasemanagementcareblog.blogspot.com)
- 15 things you shold know about the final rule of the Physician Payment Sunshine Act (medcitynews.com)
- Let the Sunshine In…… (policykina.com)
- Here comes the Sun(shine Act) … and it’s not going to be alright for pharma and device reps (medcitynews.com)
- CMS Delayed Final Rule On Payments To Physicians Released (medicalnewstoday.com)
- Medical Industry Must Disclose Doctor Payments, U.S. Says – Bloomberg (bloomberg.com)
- 5 things you can do now to prepare for the Sunshine Act (medcitynews.com)
- Feds to Publicize Drug and Device Company Payments to Doctors Next Year (propublica.org)
- No Sunshine For Continuing Medical Education (forbes.com)
- Tips for Finding Good Orthopedic Surgeons (orthopedics.answers.com)